No Data
No Data
ReproCELL: Extraordinary Report
ReproCELL FY Loss Y31.00M Vs Loss Y305.00M
ReproCELL Inc. (4978.TO) Japan Year Ended March 31 GROUP 2024 2023 Revenue Y2.43 bln Y2.95 bln Operating Profit (Y409.00 mln) (Y35
ReproCELL: Notice regarding differences between full-year individual results for the fiscal year ending March 31, 2024 and results for the previous fiscal year
ReproCELL: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
Taiseiken, Obayashi Corporation, Toray, Shiono Yoshi (13th) (1417-5070)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------5/13 (Mon) <1417>Miraite One <1435>Robohome<146A>Colombia <1515>Nippon Steel Mining <1518>Mitsui Matsushima HD <1663>K&O Energy<167A>Ryosan Ryoyo <1736>Autech <174
Steady, supported by observations of lower US interest rates
[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to develop steadily. In the US stock market yesterday 7th, the Dow Average continued to rise slightly for 5 days to 38,884.26 dollars, which was 31.99 dollars higher (+ 0.08%). While expectations for interest rate cuts continued, a decline in long-term interest rates and expectations for corporate settlement supported stock prices. Meanwhile, since President Kashkari of the Minneapolis Fed showed an attitude of not ruling out interest rate hikes, it stalled towards the end of the game. The Nasdaq Composite Index turned down. Buying is excellent in today's emerging markets
No Data